Blockade of the passive cell death pathway does not prevent tolerance induction to islet grafts

Transplantation. 2007 Mar 15;83(5):653-5. doi: 10.1097/01.tp.0000255592.09784.ba.

Abstract

Background: T-cell apoptosis is an important regulatory mechanism in transplant tolerance. The aim of this study was to identify specific apoptotic molecules important for tolerance induction.

Methods: Mice expressing the human Bcl-2 molecule in T cells or Bim -/- mice were used as islet allograft or rat islet xenograft recipients and treated with CTLA4-Fc and MR1 costimulation blockade.

Results: hBcl-2 transgenic mice and Bim -/- accepted islet allografts and rat islet xenografts for more than 100 days, similar to wildtype controls. Changes in the dose of the CTLA4-Fc and MR1 did not lead to differences in graft survival and there were no differences in the percentage of CD4+ T cells expressing Fas, CD25, or undergoing apoptosis.

Conclusions: Inhibition of the passive cell death pathway in T cells did not block tolerance induction, suggesting that the mechanism by which apoptosis regulates the alloimmune response is more complex than first thought.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abatacept
  • Animals
  • Animals, Genetically Modified
  • Cell Death / physiology*
  • Graft Survival
  • Humans
  • Immune Tolerance*
  • Immunoconjugates / genetics
  • Islets of Langerhans Transplantation / immunology*
  • Mice
  • Mice, Transgenic
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Rats

Substances

  • Immunoconjugates
  • Proto-Oncogene Proteins c-bcl-2
  • Abatacept